AI Article Synopsis

  • The study focused on comparing the effectiveness and reproducibility of an automated assay (Xpert BCR-ABL Monitor™) versus non-automated methods for monitoring chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
  • Results showed that the automated assays had similar reproducibility to standardized non-automated assays, and converting automated results to the international scale was feasible, though cost-effectiveness favored automation for lower sample volumes.
  • The findings suggest that the Xpert BCR-ABL Monitor™ could be used effectively in routine clinical settings, but further research is needed to determine its prognostic value compared to non-automated methods.

Article Abstract

Background: Molecular monitoring of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors is essential for therapeutic stratification. Inter-laboratory reproducibility is, therefore, a crucial issue which requires standardization and strict alignment of BCR-ABL1 values to the international scale. An automated cartridge-based assay (Xpert BCR-ABL Monitor(™), Cepheid) had been proposed as a robust alternative to non-automated assays. This study aimed to compare inter-laboratory reproducibility of automated and non-automated quantification, the possibility of converting automated results to the international scale, and the potential economic impact of automation.

Design And Methods: One hundred and eighteen blood samples from chronic myeloid leukemia patients treated with tyrosine kinase inhibitors were prospectively analyzed in two laboratories using both automated and non-automated assays. The economic evaluation involved a micro-costing study and average costs were assessed as a function of sample throughput.

Results: Automated assays achieved similar inter-laboratory reproducibility to highly standardized non-automated assays and a short delay (≤6 h) between sampling and blood lysis had a positive impact on inter-laboratory reproducibility. Reporting automated BCR-ABL1 ratios on the international scale was possible using a specific conversion factor which may vary with batches. Cost assessment showed that automated assays could be relevant for annual activity levels below 300 since average costs were lower than those of the non-automated assays.

Conclusions: The Xpert BCR-ABL Monitor(™) assay could be appropriately used in a near-patient setting for routine quantification of e13/e14-a2 transcripts, preferably in partnership with a regional reference laboratory. However, its prognostic impact relative to non-automated quantification remains to be tested prospectively within appropriate clinical trials.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084912PMC
http://dx.doi.org/10.3324/haematol.2010.034389DOI Listing

Publication Analysis

Top Keywords

inter-laboratory reproducibility
16
international scale
12
non-automated assays
12
automated bcr-abl1
8
chronic myeloid
8
myeloid leukemia
8
leukemia patients
8
patients treated
8
treated tyrosine
8
tyrosine kinase
8

Similar Publications

Validation of lactate and glucose in cerebrospinal fluid (CSF) on a Radiometer blood gas analyzer ABL90 Flex plus.

Clin Biochem

January 2025

Pathology and Laboratory Medicine Program, Health Sciences Centre, St. John's, Newfoundland and Labrador, Canada; Memorial University of Newfoundland, Health Sciences Centre, St. John's, Newfoundland and Labrador, Canada. Electronic address:

Purpose: Rapid determination of cerebrospinal fluid. (CSF) glucose and lactate is required by emergency rooms and intensive care units. Long turnaround time (TAT) on test results negatively impacts timely diagnosis and treatment of neurological infections like meningitis.

View Article and Find Full Text PDF

The increasing interest in DNA methylation (DNAm) analysis within the forensic scientific community prompted a collaborative project by Ge.F.I.

View Article and Find Full Text PDF

Enhancing reproducibility in single cell research with biocytometry: An inter-laboratory study.

PLoS One

December 2024

Department of Research & Development, Sampling Human Inc., Berkeley, California, United States of America.

Article Synopsis
  • Biomedicine is moving towards decentralized data collection, which improves reproducibility and collaboration across labs.
  • A study evaluated biocytometry, a method using engineered bioparticles, and found it effective for counting target cells at low concentrations, even with varying user expertise.
  • The findings suggest that biocytometry is a practical option for immunophenotyping, allowing for sensitive and scalable analysis of rare cells in diverse samples without needing advanced training.
View Article and Find Full Text PDF
Article Synopsis
  • Immunosuppressive medication dosing after organ transplantation typically relies on therapeutic drug monitoring, but this method may not effectively predict rejection or infections.
  • The TTVguideIT trial investigates using Torque Teno Virus (TTV) load measurement via qPCR as a potentially better alternative for dosing tacrolimus.
  • Results demonstrated that the TTV R-GENE® assay showed excellent accuracy and consistency across participating labs, allowing for standardized TTV load measurement in clinical trials.
View Article and Find Full Text PDF

How reliable is the evaluation of DNA binding constants? Insights and best practices based on an inter-laboratory fluorescence titration study.

Spectrochim Acta A Mol Biomol Spectrosc

February 2025

Department of Chemistry and Industrial Chemistry, University of Pisa, Via G. Moruzzi 13, 56124 Pisa, Italy. Electronic address:

In all experimental sciences, the precision and reliability of quantitative measurements are paramount. This is particularly true when examining the interactions between small molecules and biomolecules/polyelectrolytes, such as DNAs/RNAs, and yet it is overlooked in most publications of thermodynamic binding parameters. This paper presents findings from COST Action 18202 "Network for Equilibria and Chemical Thermodynamics Advanced Research," which assessed the consistency of data derived from the interactions of calf-thymus DNA (CT-DNA) with the fluorescent intercalator ethidium bromide (EB) through spectrofluorimetric titrations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!